Literature DB >> 1441917

Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats.

G Cavaletti1, G Tredici, P Marmiroli, M G Petruccioli, I Barajon, D Fabbrica.   

Abstract

We performed a morphological, morphometric and toxicological study on the spinal ganglia and peripheral nerves of the rat after chronic administration of cisplatin (cis-dichlorodiammineplatinum II; DDP) with two different schedules. Severe damage of the spinal ganglia neurons was demonstrated with predominant involvement of the nucleus and nucleolus associated with a decrease in the cell size. Morphological and morphometric changes also occurred in the sciatic and peroneal nerves with the features of axonopathy. All these changes were more marked in the group of rats which underwent the most intense DDP treatment and the tissue platinum concentrations were also higher in this group. This experimental model is the first available for chronic DDP administration in which concomitant spinal ganglia and peripheral nerve damage has been confirmed pathologically. Our study supports the hypothesis that DDP-induced peripheral nerve fiber degeneration may result from nuclear and nucleolar changes in the sensory ganglion cell perikaryon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1441917     DOI: 10.1007/bf00227662

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum(II) treatment: a case report.

Authors:  A Kedar; M E Cohen; A I Freeman
Journal:  Cancer Treat Rep       Date:  1978-05

2.  Cisplatin neurotoxicity.

Authors:  J E Mollman
Journal:  N Engl J Med       Date:  1990-01-11       Impact factor: 91.245

Review 3.  Fundamental studies with cisplatin.

Authors:  B Rosenberg
Journal:  Cancer       Date:  1985-05-15       Impact factor: 6.860

4.  Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseases axons.

Authors:  P S Spencer; P K Thomas
Journal:  J Neurocytol       Date:  1974-12

5.  Prospective study of nerve conduction parameters and serum magnesium following cisplatin therapy.

Authors:  M Ashraf; J E Riggs; S Wearden; P Scotchel
Journal:  Gynecol Oncol       Date:  1990-04       Impact factor: 5.482

6.  Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment.

Authors:  D Hadley; H W Herr
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

7.  Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

Authors:  S W Thompson; L E Davis; M Kornfeld; R D Hilgers; J C Standefer
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

8.  Electrophysiological study of the peripheral and central neurotoxic effect of cis-platin.

Authors:  G K Daugaard; J Petrera; W Trojaborg
Journal:  Acta Neurol Scand       Date:  1987-08       Impact factor: 3.209

9.  Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity.

Authors:  G Cavaletti; L Marzorati; G Bogliun; N Colombo; M Marzola; M R Pittelli; G Tredici
Journal:  Cancer       Date:  1992-01-01       Impact factor: 6.860

10.  The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and by morphometry.

Authors:  K Tomiwa; C Nolan; J B Cavanagh
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more
  48 in total

1.  The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies.

Authors:  Mansour S Al Moundhri; Suhail Al-Salam; Ahmed Al Mahrouqee; S Beegam; Badreldin H Ali
Journal:  J Med Toxicol       Date:  2013-03

Review 2.  Emerging trends in understanding chemotherapy-induced peripheral neuropathy.

Authors:  Jérémy Ferrier; Vanessa Pereira; Jérome Busserolles; Nicolas Authier; David Balayssac
Journal:  Curr Pain Headache Rep       Date:  2013-10

3.  Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration.

Authors:  G Tredici; S Tredici; D Fabbrica; C Minoia; G Cavaletti
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

Review 4.  Peripheral neuropathy in children and adolescents treated for cancer.

Authors:  Kari L Bjornard; Laura S Gilchrist; Hiroto Inaba; Barthelemy Diouf; Marilyn J Hockenberry; Nina S Kadan-Lottick; Daniel C Bowers; M Eileen Dolan; Nicole J Ullrich; William E Evans; Kirsten K Ness
Journal:  Lancet Child Adolesc Health       Date:  2018-09-01

Review 5.  Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

Authors:  Wolfgang Grisold; Guido Cavaletti; Anthony J Windebank
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

6.  Protective effect of amifostine against cisplatin-induced motor neuropathy in rat.

Authors:  Suayib Yalcin; Gulay Nurlu; Bülent Orhan; Dilara Zeybek; Sevda Müftüoğlu; Banu Sarer; Berna Akkuş Yildirim; Eren Cetin
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

7.  Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y.

Authors:  Elisabetta Donzelli; Maria Carfì; Mariarosaria Miloso; Alberto Strada; Stefania Galbiati; Martine Bayssas; Genevieve Griffon-Etienne; Guido Cavaletti; Maria Grazia Petruccioli; Giovanni Tredici
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

8.  Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.

Authors:  Virginia Ip; Johnson J Liu; Julian F B Mercer; Mark J McKeage
Journal:  Mol Pain       Date:  2010-09-13       Impact factor: 3.395

Review 9.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

10.  Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity.

Authors:  S M F Jamieson; J Liu; T Hsu; B C Baguley; M J McKeage
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.